Call: Pilot project INTEGRATE: Development of integrated strategies to monitor and treat chronic and rheumatic diseases
|Type of Fund||Action programme|
|Description of programme |
"Health Programme "
The EU is required by its founding treaty to ensure that human health is protected as part of all its policies, and to work with the EU countries to improve public health, prevent human illness and eliminate sources of danger to physical and mental health. The 3rd Health Programme has 4 overarching objectives:
|Link||Link to Programme|
Pilot project INTEGRATE: Development of integrated strategies to monitor and treat chronic and rheumatic diseases
|Description of call |
" Pilot project INTEGRATE: Development of integrated strategies to monitor and treat chronic and rheumatic diseases"
of integrated strategies to monitor and treat chronic and rheumatic diseases - the role of quality indicators and patient
reported outcomes in addition to the physician evaluation of disease activity and damage |
It is generally acknowledged that the clinical picture observed in many chronic diseases (such as diabetes, cardiovascular diseases, neurological disorders and rheumatic diseases) is the result of the combination of different components: disease activity, damage consequent to the disease itself or the treatment, comorbidities, drug toxicity, quality of life and disease burden on patients. Therefore, optimal treatment and management of chronic diseases means that these aspects have to be factored in.
In particular, musculo-skeletal diseases such as rheumatic diseases are often associated with other chronic conditions, such as diabetes, other autoimmune diseases, and cardiovascular, or mental diseases, such as depression. However, chronic musculoskeletal conditions are not always considered priorities in chronic disease prevention.
This pilot project should thus focus on exploring the potential of specific quality indicators, and patient-reported outcomes in addition to the more traditional reports of physicians towards developing an effective strategy to prevent and treat musculoskeletal diseases such as rheumatic diseases, focusing on rheumatic connective tissue diseases, taking multimorbidity as well as integrated care for such patients into account.
|Link||Link to Call|
|Thematic Focus||Health, Research|
|Funding area|| EU Member States |
|Origin of Applicant|| EU Member States |
Iceland / Ísland
Norway / Norge
|Eligible applicants||Public Services, University, Research Institution|
|Project Partner Details|| Proposals must be submitted by consortia of legal entities
(with or without legal personality) established in at least 2 different EU Member States. |
|Project duration max||24 months|
|Type of Funding||Grants|
|Financial details||The total budget earmarked for the co-financing of projects is estimated at 500 000 €. The maximum possible rate of co-financing of the eligible total costs is 60%.|